Results of studies on blood NFL are less clear-cut, with some investigations not reporting significant differences in serum NFL between bvFTD cases with and without gene mutations or between FTD patients with mutations in different genes (Rohrer et al., 2016; Steinacker et al., 2018). The gene discussed is NEFL; the disease is frontotemporal dementia.